TipRanks
Syndax Pharmaceuticals Inc (DE:1T3)
FRANKFURT:1T3
Germany Market

Syndax Pharmaceuticals (1T3) Balance Sheet

4 Followers

Syndax Pharmaceuticals Balance Sheet

Syndax Pharmaceuticals's total assets for Q2 2026 were $703.65M, an increase of 48.87% from the previous quarter. DE:1T3 total liabilities were $688.55M for the fiscal quarter, a 59.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 529.71M$ 724.82M$ 612.88M$ 497.24M$ 449.66M
Total Liabilities
$ 465.08M$ 436.69M$ 58.68M$ 29.79M$ 41.29M
Total Equity Gross Minority
$ 64.63M$ 288.12M$ 554.20M$ 467.45M$ 408.37M
Other Metrics
Currency in USD

Syndax Pharmaceuticals Debt to Assets